comparemela.com

Latest Breaking News On - Ife sciences company repligen - Page 1 : comparemela.com

Repligen Q3 Results Top Estimates; Boosts FY23 Earnings Outlook

Life sciences company Repligen Corp. (RGEN) announced Tuesday third-quarter net income of $18.17 million or $0.32 per share, sharply down from $40.41 million or $0.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.